Author

S. Aboulouard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 5 Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:non-human primate· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

I. Fournier· 5 shared M. Salzet· 5 shared M. Wisztorski· 3 shared F. Kobeissy· 2 shared L. Drelich· 2 shared M. Duhamel· 2 shared T. Cardon· 2 shared A. Raffo Romero· 1 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

I. Fournier

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Establishment and characterization of a tumoroid biobank derived from dog patients' mammary tumors for translational research

A. Raffo-Romero, S. Aboulouard, E. Bouchaert, A. Rybicka, D. Tierny, N. Hajjaji, I. Fournier, M. Salzet, M. Duhamel

This paper establishes a canine mammary tumoroid biobank that mirrors human breast cancer in molecular and histological features, demonstrating its utility as a preclinical drug screening model.

bioRxiv · Sep 4, 2022 · PreprintCancer Biology

Towards high spatially resolved microproteomics using expansion microscopy

L. Drelich, S. Aboulouard, J. Franck, M. Salzet, I. Fournier, M. Wisztorski

This paper develops a method to combine expansion microscopy with microproteomics to enable spatially resolved protein analysis at high resolution.

bioRxiv · Mar 3, 2021Biochemistry

Overall patient's survival of glioblastoma associated to molecular markers: a pan-proteomic prospective study

L. Drelich, M. Duhamel, M. Wisztorski, S. Aboulouard, J.-p. Gimeno, P.-d. Caux, N. Ogrinc, P. Devos, T. Cardon, M. Weller, F. Escande, F. Zairi, C.-A. Maurage, I. Fournier, E. Le rhun, M. Salzet

This paper identifies three molecular groups of glioblastoma (GBM) associated with different survival outcomes using pan-proteomic analysis and validates prognostic markers for improved patient stratification.

bioRxiv · Nov 24, 2020 · PreprintCancer Biology

Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSC

M. Wisztorski, P. saudemont, s. aboulouard, t. cardon, f. narducci, y.-m. robin, A.-s. Lemaire, D. Bertin, F. Kobeissy, E. Leblanc, I. Fournier, M. Salzet

The paper analyzes proteomic data from preneoplastic lesions in fallopian tubes to identify early diagnostic markers for HGSC and support fimbriectomy benefits for BRCA1/2 patients.

bioRxiv · Oct 4, 2020 · PreprintCancer Biology

On-tissue spatially-resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape

S. A. Malaker, J. Quanico, A. Raffo Romero, F. Kobeissy, S. Aboulouard, C. R. Bertozzi, I. Fournier, M. Salzet

This paper develops a spatially-resolved glycoproteomics approach combining MALDI imaging and LC-MS/MS to identify glycan patterns in canine gliomas, revealing dysregulated glycosylation in tumor and necrotic regions.

bioRxiv · Oct 2, 2020Cancer Biology